Compare NGL & BHVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | NGL | BHVN |
|---|---|---|
| Founded | 1940 | 2013 |
| Country | United States | United States |
| Employees | 569 | N/A |
| Industry | Natural Gas Distribution | Biotechnology: Pharmaceutical Preparations |
| Sector | Utilities | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.6B | 1.4B |
| IPO Year | N/A | 2022 |
| Metric | NGL | BHVN |
|---|---|---|
| Price | $16.15 | $9.57 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 14 |
| Target Price | N/A | ★ $29.08 |
| AVG Volume (30 Days) | 202.5K | ★ 1.6M |
| Earning Date | 05-28-2026 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 26.08 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $366.01 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $3.10 | $7.48 |
| 52 Week High | $16.69 | $18.57 |
| Indicator | NGL | BHVN |
|---|---|---|
| Relative Strength Index (RSI) | 66.45 | 48.49 |
| Support Level | $9.28 | $9.26 |
| Resistance Level | N/A | $10.22 |
| Average True Range (ATR) | 0.73 | 0.72 |
| MACD | 0.08 | -0.02 |
| Stochastic Oscillator | 82.56 | 37.87 |
NGL Energy Partners LP is a USA-based firm that owns and operates a vertically integrated energy business. The company's operating segments include Crude Oil Logistics, Water Solutions, and Liquids Logistics. It operates crude oil Logistics, owns pipeline injection stations, and offers services for the treatment and disposal of wastewater generated from crude oil and natural gas production, as well as for the disposal of solids, such as tank bottoms and drilling fluids. The firm also supplies natural gas liquids to retailers, wholesalers, refiners, and petrochemical plants and sells propane and distillates.
Biohaven Ltd is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of life-changing treatments in key therapeutic areas, including immunology, neuroscience, and oncology. Its product pipeline includes Glutamate, Myostatin, Ion channels, Inflammation & Immunology, and Oncology. The company's products target diseases such as neuromuscular and metabolic diseases, antibody-drug conjugates for cancer, obsessive-compulsive disorder and others. Its pipeline products include: BHV-2000, BHV-7000, BHV-2100, BHV-8000, BHV-1310, BHV-1300, BHV-1400, BHV-1600, BHV-1530, and BHV-1500.